592 related articles for article (PubMed ID: 18539963)
1. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
Glinsky GV
J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
[TBL] [Abstract][Full Text] [Related]
2. Ensemble methods for classification of patients for personalized medicine with high-dimensional data.
Moon H; Ahn H; Kodell RL; Baek S; Lin CJ; Chen JJ
Artif Intell Med; 2007 Nov; 41(3):197-207. PubMed ID: 17719213
[TBL] [Abstract][Full Text] [Related]
3. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
Dressman HK; Berchuck A; Chan G; Zhai J; Bild A; Sayer R; Cragun J; Clarke J; Whitaker RS; Li L; Gray J; Marks J; Ginsburg GS; Potti A; West M; Nevins JR; Lancaster JM
J Clin Oncol; 2007 Feb; 25(5):517-25. PubMed ID: 17290060
[TBL] [Abstract][Full Text] [Related]
4. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
Glinsky GV
Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
[TBL] [Abstract][Full Text] [Related]
5. Stem cell origin of death-from-cancer phenotypes of human prostate and breast cancers.
Glinsky GV
Stem Cell Rev; 2007 Jan; 3(1):79-93. PubMed ID: 17873385
[TBL] [Abstract][Full Text] [Related]
6. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS
Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
[TBL] [Abstract][Full Text] [Related]
7. Microarrays in breast cancer research and clinical practice--the future lies ahead.
Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
[TBL] [Abstract][Full Text] [Related]
8. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.
Yu J; Yu J; Rhodes DR; Tomlins SA; Cao X; Chen G; Mehra R; Wang X; Ghosh D; Shah RB; Varambally S; Pienta KJ; Chinnaiyan AM
Cancer Res; 2007 Nov; 67(22):10657-63. PubMed ID: 18006806
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior.
Lu YJ; Williamson D; Wang R; Summersgill B; Rodriguez S; Rogers S; Pritchard-Jones K; Campbell C; Shipley J
Genes Chromosomes Cancer; 2003 Nov; 38(3):207-14. PubMed ID: 14506694
[TBL] [Abstract][Full Text] [Related]
10. Genomic strategies for personalized cancer therapy.
Garman KS; Nevins JR; Potti A
Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
[TBL] [Abstract][Full Text] [Related]
11. Hunting for robust gene signature from cancer profiling data: sources of variability, different interpretations, and recent methodological developments.
Xu JZ; Wong CW
Cancer Lett; 2010 Oct; 296(1):9-16. PubMed ID: 20579805
[TBL] [Abstract][Full Text] [Related]
12. Genomic approaches to outcome prediction in prostate cancer.
Febbo PG
Cancer; 2009 Jul; 115(13 Suppl):3046-57. PubMed ID: 19544546
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays.
Mobasheri A; Airley R; Hewitt SM; Marples D
Int J Oncol; 2005 May; 26(5):1149-58. PubMed ID: 15809704
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling on lung cancer outcome prediction: present clinical value and future premise.
Sun Z; Yang P
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2063-8. PubMed ID: 17119029
[TBL] [Abstract][Full Text] [Related]
15. Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction.
Nevins JR; Huang ES; Dressman H; Pittman J; Huang AT; West M
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R153-7. PubMed ID: 12928487
[TBL] [Abstract][Full Text] [Related]
16. Cancer gene profiling for response prediction.
Ghadimi BM; Grade M
Methods Mol Biol; 2010; 576():327-39. PubMed ID: 19882269
[TBL] [Abstract][Full Text] [Related]
17. Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.
Anguiano A; Potti A
Expert Rev Mol Diagn; 2007 Nov; 7(6):837-44. PubMed ID: 18020912
[TBL] [Abstract][Full Text] [Related]
18. Moving toward individualized cancer therapies.
Tonon G; Anderson KC
Clin Cancer Res; 2008 Aug; 14(15):4682-4. PubMed ID: 18676734
[TBL] [Abstract][Full Text] [Related]
19. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
Miller LD; Liu ET
Breast Cancer Res; 2007; 9(2):206. PubMed ID: 17397520
[TBL] [Abstract][Full Text] [Related]
20. Role of oncoproteomics in the personalized management of cancer.
Jain KK
Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
